Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Machine learning vs addiction therapists: A pilot study predicting alcohol dependence treatment outcome from patient data in behavior therapy with adjunctive medication.

Symons M, Feeney GFX, Gallagher MR, Young RM, Connor JP.

J Subst Abuse Treat. 2019 Apr;99:156-162. doi: 10.1016/j.jsat.2019.01.020. Epub 2019 Jan 30.

PMID:
30797388
2.

A systematic review of prevention interventions to reduce prenatal alcohol exposure and fetal alcohol spectrum disorder in indigenous communities.

Symons M, Pedruzzi RA, Bruce K, Milne E.

BMC Public Health. 2018 Nov 3;18(1):1227. doi: 10.1186/s12889-018-6139-5. Review.

3.

PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.

Ding Z, Dhruv H, Kwiatkowska-Piwowarczyk A, Ruggieri R, Kloss J, Symons M, Pirrotte P, Eschbacher JM, Tran NL, Loftus JC.

Neoplasia. 2018 Oct;20(10):1045-1058. doi: 10.1016/j.neo.2018.08.008. Epub 2018 Sep 13.

4.

Predicting Language Difficulties in Middle Childhood From Early Developmental Milestones: A Comparison of Traditional Regression and Machine Learning Techniques.

Armstrong R, Symons M, Scott JG, Arnott WL, Copland DA, McMahon KL, Whitehouse AJO.

J Speech Lang Hear Res. 2018 Aug 8;61(8):1926-1944. doi: 10.1044/2018_JSLHR-L-17-0210.

PMID:
30073346
5.

The provision of alcohol and breastfeeding information by maternal health practitioners in the Australian setting.

Giglia RC, Symons M, Shaw T.

Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):258-264. doi: 10.1111/ajo.12837. Epub 2018 Jun 21.

PMID:
29926916
6.

Intratibial Injection Causes Direct Pulmonary Seeding of Osteosarcoma Cells and Is Not a Spontaneous Model of Metastasis: A Mouse Osteosarcoma Model.

Maloney C, Edelman MC, Kallis MP, Soffer SZ, Symons M, Steinberg BM.

Clin Orthop Relat Res. 2018 Jul;476(7):1514-1522. doi: 10.1007/s11999.0000000000000291.

7.

Study protocol for a self-controlled cluster randomised trial of the Alert Program to improve self-regulation and executive function in Australian Aboriginal children with fetal alcohol spectrum disorder.

Wagner B, Fitzpatrick JP, Mazzucchelli TG, Symons M, Carmichael Olson H, Jirikowic T, Cross D, Wright E, Adams E, Carter M, Bruce K, Latimer J.

BMJ Open. 2018 Mar 25;8(3):e021462. doi: 10.1136/bmjopen-2017-021462.

8.

Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism.

Markowitz D, Ha G, Ruggieri R, Symons M.

Onco Targets Ther. 2017 Nov 24;10:5633-5642. doi: 10.2147/OTT.S143096. eCollection 2017.

9.

Colony Stimulating Factor-1 Receptor Inhibitors-A 4 for 1 Deal in the Desire to Improve Glioma Radiotherapy.

Skeie B, Ruggieri R, Boockvar JA, Symons M.

Neurosurgery. 2017 Sep 1;81(3):N27-N28. doi: 10.1093/neuros/nyx389. No abstract available.

PMID:
28859456
10.

Brown Carbon Production in Ammonium- or Amine-Containing Aerosol Particles by Reactive Uptake of Methylglyoxal and Photolytic Cloud Cycling.

De Haan DO, Hawkins LN, Welsh HG, Pednekar R, Casar JR, Pennington EA, de Loera A, Jimenez NG, Symons MA, Zauscher M, Pajunoja A, Caponi L, Cazaunau M, Formenti P, Gratien A, Pangui E, Doussin JF.

Environ Sci Technol. 2017 Jul 5;51(13):7458-7466. doi: 10.1021/acs.est.7b00159. Epub 2017 Jun 14.

PMID:
28562016
11.

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors.

De Witt M, Gamble A, Hanson D, Markowitz D, Powell C, Al Dimassi S, Atlas M, Boockvar J, Ruggieri R, Symons M.

Mol Med. 2017 Apr;23:50-56. doi: 10.2119/molmed.2017.00011. Epub 2017 Apr 5.

12.

Milk fat globule-epidermal growth factor-factor VIII-derived peptide MSP68 is a cytoskeletal immunomodulator of neutrophils that inhibits Rac1.

Hendricks L, Aziz M, Yang WL, Nicastro J, Coppa GF, Symons M, Wang P.

J Surg Res. 2017 Feb;208:10-19. doi: 10.1016/j.jss.2016.08.098. Epub 2016 Sep 9.

13.

The development of a culturally appropriate school based intervention for Australian Aboriginal children living in remote communities: A formative evaluation of the Alert Program® intervention.

Wagner B, Fitzpatrick J, Symons M, Jirikowic T, Cross D, Latimer J.

Aust Occup Ther J. 2017 Jun;64(3):243-252. doi: 10.1111/1440-1630.12352. Epub 2016 Dec 13.

PMID:
27966224
14.

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion.

Coniglio S, Miller I, Symons M, Segall JE.

J Vis Exp. 2016 Oct 20;(116). doi: 10.3791/53990.

15.

Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma.

Mukherjee S, Baidoo J, Fried A, Atwi D, Dolai S, Boockvar J, Symons M, Ruggieri R, Raja K, Banerjee P.

Int J Cancer. 2016 Dec 15;139(12):2838-2849. doi: 10.1002/ijc.30398. Epub 2016 Sep 24.

16.

Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma.

Markowitz D, Powell C, Tran NL, Berens ME, Ryken TC, Vanan M, Rosen L, He M, Sun S, Symons M, Al-Abed Y, Ruggieri R.

Mol Cancer Ther. 2016 Aug;15(8):1799-808. doi: 10.1158/1535-7163.MCT-15-0849. Epub 2016 May 20.

17.

Radioresistance of Brain Tumors.

Kelley K, Knisely J, Symons M, Ruggieri R.

Cancers (Basel). 2016 Mar 30;8(4). pii: E42. doi: 10.3390/cancers8040042. Review.

18.

Neuro-oncology biotech industry progress report.

Chakraborty S, Bodhinayake I, Chiluwal A, Langer DJ, Ruggieri R, Symons M, Boockvar JA.

J Neurooncol. 2016 May;128(1):175-182. doi: 10.1007/s11060-016-2087-z. Epub 2016 Feb 20. Review.

PMID:
26897014
19.

SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.

Ensign SP, Roos A, Mathews IT, Dhruv HD, Tuncali S, Sarkaria JN, Symons MH, Loftus JC, Berens ME, Tran NL.

Mol Cancer Res. 2016 Mar;14(3):302-12. doi: 10.1158/1541-7786.MCR-15-0183. Epub 2016 Jan 13.

20.

The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation.

Hesketh AJ, Maloney C, Behr CA, Edelman MC, Glick RD, Al-Abed Y, Symons M, Soffer SZ, Steinberg BM.

PLoS One. 2015 Dec 28;10(12):e0145197. doi: 10.1371/journal.pone.0145197. eCollection 2015.

21.

Celecoxib inhibits Ewing sarcoma cell migration via actin modulation.

Behr CA, Hesketh AJ, Barlow M, Glick RD, Symons M, Steinberg BM, Soffer SZ.

J Surg Res. 2015 Oct;198(2):424-33. doi: 10.1016/j.jss.2015.03.085. Epub 2015 Apr 2.

PMID:
25934222
22.

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Ben-Chetrit N, Chetrit D, Russell R, Körner C, Mancini M, Abdul-Hai A, Itkin T, Carvalho S, Cohen-Dvashi H, Koestler WJ, Shukla K, Lindzen M, Kedmi M, Lauriola M, Shulman Z, Barr H, Seger D, Ferraro DA, Pareja F, Gil-Henn H, Lapidot T, Alon R, Milanezi F, Symons M, Ben-Hamo R, Efroni S, Schmitt F, Wiemann S, Caldas C, Ehrlich M, Yarden Y.

Sci Signal. 2015 Jan 20;8(360):ra7. doi: 10.1126/scisignal.2005537.

PMID:
25605973
23.

Repurposing mebendazole for the treatment of medulloblastoma.

Bodhinayake I, Symons M, Boockvar JA.

Neurosurgery. 2015 Feb;76(2):N15-6. doi: 10.1227/01.neu.0000460594.93803.cb. No abstract available.

PMID:
25594199
24.

Semapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microglia.

Miller IS, Didier S, Murray DW, Turner TH, Issaivanan M, Ruggieri R, Al-Abed Y, Symons M.

PLoS One. 2014 May 9;9(5):e95885. doi: 10.1371/journal.pone.0095885. eCollection 2014.

25.

Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation.

Murray DW, Didier S, Chan A, Paulino V, Van Aelst L, Ruggieri R, Tran NL, Byrne AT, Symons M.

Br J Cancer. 2014 Mar 4;110(5):1307-15. doi: 10.1038/bjc.2014.39. Epub 2014 Feb 11.

26.

The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.

Khalil BD, Hanna S, Saykali BA, El-Sitt S, Nasrallah A, Marston D, El-Sabban M, Hahn KM, Symons M, El-Sibai M.

Exp Cell Res. 2014 Feb 15;321(2):109-22. doi: 10.1016/j.yexcr.2013.11.023. Epub 2013 Dec 10.

27.

The Worcestershire Prostate Cancer Survivorship Programme.

Goonewardene SS, Symons M, Sullivan A, Thrush S, Makar AA, Young A.

Br J Gen Pract. 2013 Nov;63(616):574-5. doi: 10.3399/bjgp13X674378. No abstract available.

28.

Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression.

Fortin Ensign SP, Mathews IT, Symons MH, Berens ME, Tran NL.

Front Oncol. 2013 Oct 4;3:241. doi: 10.3389/fonc.2013.00241. Review.

30.

Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia.

Hollingworth SA, Symons M, Khatun M, Loveday B, Ballantyne S, Hall WD, Najman JM.

Aust N Z J Public Health. 2013 Apr;37(2):132-8. doi: 10.1111/1753-6405.12030.

PMID:
23551471
31.

The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.

Korkina O, Dong Z, Marullo A, Warshaw G, Symons M, Ruggieri R.

J Biol Chem. 2013 Feb 22;288(8):5364-73. doi: 10.1074/jbc.M112.414060. Epub 2013 Jan 14.

32.

Regulation of synaptojanin 2 5'-phosphatase activity by Src.

Chuang Y, Xu X, Kwiatkowska A, Tsapraillis G, Hwang H, Petritis K, Flynn D, Symons M.

Cell Adh Migr. 2012 Nov-Dec;6(6):518-25. doi: 10.4161/cam.22139. Epub 2012 Oct 17.

33.

The small GTPase RhoG mediates glioblastoma cell invasion.

Kwiatkowska A, Didier S, Fortin S, Chuang Y, White T, Berens ME, Rushing E, Eschbacher J, Tran NL, Chan A, Symons M.

Mol Cancer. 2012 Sep 11;11:65. doi: 10.1186/1476-4598-11-65.

34.

Signaling determinants of glioma cell invasion.

Kwiatkowska A, Symons M.

Adv Exp Med Biol. 2013;986:121-41. doi: 10.1007/978-94-007-4719-7_7. Review.

PMID:
22879067
35.

Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.

Fortin SP, Ennis MJ, Schumacher CA, Zylstra-Diegel CR, Williams BO, Ross JT, Winkles JA, Loftus JC, Symons MH, Tran NL.

Mol Cancer Res. 2012 Jul;10(7):958-68. doi: 10.1158/1541-7786.MCR-11-0616. Epub 2012 May 9.

36.

Role of a DNA damage checkpoint pathway in ionizing radiation-induced glioblastoma cell migration and invasion.

Vanan I, Dong Z, Tosti E, Warshaw G, Symons M, Ruggieri R.

Cell Mol Neurobiol. 2012 Oct;32(7):1199-208. Epub 2012 May 3.

PMID:
22552889
37.

Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.

Coniglio SJ, Eugenin E, Dobrenis K, Stanley ER, West BL, Symons MH, Segall JE.

Mol Med. 2012 May 9;18:519-27. doi: 10.2119/molmed.2011.00217.

38.

Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.

Song X, Andrew Allen R, Terence Dunn S, Fung KM, Farmer P, Gandhi S, Ranjan T, Demopoulos A, Symons M, Schulder M, Li JY.

Int J Clin Exp Pathol. 2011;4(7):651-60. Epub 2011 Sep 17.

39.

Rac1 activation comes full circle.

Symons M.

EMBO J. 2011 Oct 5;30(19):3875-7. doi: 10.1038/emboj.2011.330. No abstract available.

40.

Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach.

Vader P, van der Meel R, Symons MH, Fens MH, Pieters E, Wilschut KJ, Storm G, Jarzabek M, Gallagher WM, Schiffelers RM, Byrne AT.

Angiogenesis. 2011 Dec;14(4):457-66. doi: 10.1007/s10456-011-9229-x. Epub 2011 Jul 26.

PMID:
21789714
41.

The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.

van der Meel R, Symons MH, Kudernatsch R, Kok RJ, Schiffelers RM, Storm G, Gallagher WM, Byrne AT.

Drug Discov Today. 2011 Mar;16(5-6):219-28. doi: 10.1016/j.drudis.2011.01.005. Epub 2011 Jan 22. Review.

PMID:
21262381
42.

Phosphoinositides direct equine infectious anemia virus gag trafficking and release.

Fernandes F, Chen K, Ehrlich LS, Jin J, Chen MH, Medina GN, Symons M, Montelaro R, Donaldson J, Tjandra N, Carter CA.

Traffic. 2011 Apr;12(4):438-51. doi: 10.1111/j.1600-0854.2010.01153.x. Epub 2011 Feb 1.

43.

Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood trauma.

Kingdon DG, Ashcroft K, Bhandari B, Gleeson S, Warikoo N, Symons M, Taylor L, Lucas E, Mahendra R, Ghosh S, Mason A, Badrakalimuthu R, Hepworth C, Read J, Mehta R.

J Nerv Ment Dis. 2010 Jun;198(6):399-403. doi: 10.1097/NMD.0b013e3181e08c27.

PMID:
20531117
44.

Delineation of the role of nicotinic acetylcholine receptor genes in alcohol preference in mice.

Symons MN, Weng J, Diehl E, Heo E, Kleiber ML, Singh SM.

Behav Genet. 2010 Sep;40(5):660-71. doi: 10.1007/s10519-010-9366-9. Epub 2010 May 23.

PMID:
20496163
45.

Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression.

Wu R, Abramson AL, Symons MH, Steinberg BM.

Int J Cancer. 2010 Nov 1;127(9):2230-7. doi: 10.1002/ijc.25226.

46.

Role of Rac1-regulated signaling in medulloblastoma invasion. Laboratory investigation.

Zavarella S, Nakada M, Belverud S, Coniglio SJ, Chan A, Mittler MA, Schneider SJ, Symons M.

J Neurosurg Pediatr. 2009 Aug;4(2):97-104. doi: 10.3171/2009.4.PEDS08322.

PMID:
19645540
47.

Ethanol-responsive genes (Crtam, Zbtb16, and Mobp) located in the alcohol-QTL region of chromosome 9 are associated with alcohol preference in mice.

Weng J, Symons MN, Singh SM.

Alcohol Clin Exp Res. 2009 Aug;33(8):1409-16. doi: 10.1111/j.1530-0277.2009.00971.x. Epub 2009 Apr 30.

PMID:
19413645
48.

Rac and Rho driving tumor invasion: who's at the wheel?

Symons M, Segall JE.

Genome Biol. 2009;10(3):213. doi: 10.1186/gb-2009-10-3-213. Epub 2009 Mar 6. Review.

49.

Studies on Syntaxin 12 and alcohol preference involving C57BL/6J and DBA/2J strains of mice.

Weng J, Symons MN, Singh SM.

Behav Genet. 2009 Mar;39(2):183-91. doi: 10.1007/s10519-008-9249-5. Epub 2008 Dec 24.

PMID:
19107586
50.

Role of potassium channel gene Kcnj10 in ethanol preference in C57bl/6J and DBA/2J mice.

Zou SB, Weng J, Symons MN, Singh SM.

Alcohol Clin Exp Res. 2009 Mar;33(3):394-9. doi: 10.1111/j.1530-0277.2008.00848.x. Epub 2008 Nov 25.

PMID:
19053975

Supplemental Content

Loading ...
Support Center